Literature DB >> 7403340

Influence of epinephrine on the aggregation response of aspirin-treated platelets.

G H Rao, G J Johnson, J G White.   

Abstract

We have evaluated the influence of epinephrine on the sensitivity of aspirin-treated platelets to aggregating agents. Concentrations of ADP, thrombin and arachidonate that caused reversible stimulation of aspirin platelets produced irreversible aggregation when the aspirin samples had been pretreated with epinephrine. The correction was not due to improvement in the ability of aspirin platelets to synthesize prostaglandins or secrete products of the release reaction. Epinephrine induced correction of refractory aspirin platelets may help to explain why aspirin is not a universally effective anti-thrombotic agent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7403340     DOI: 10.1016/0161-4630(80)90090-7

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  14 in total

1.  Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.

Authors:  D M Vanags; S E Rodgers; E M Duncan; J V Lloyd; F Bochner
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Platelets in perspective.

Authors:  J G White
Journal:  West J Med       Date:  1981-02

3.  Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium.

Authors:  J A Ware; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs.

Authors:  G H Rao; J G White
Journal:  Agents Actions       Date:  1985-07

5.  Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.

Authors:  F Fouque; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

6.  Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.

Authors:  C Lecrubier; J Conard; M H Horellou; M Samama
Journal:  Agents Actions       Date:  1983-02

7.  Possible mechanisms of the potentiation of blood-platelet activation by adrenaline.

Authors:  M Bushfield; A McNicol; D E MacIntyre
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

8.  The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man.

Authors:  C C Smith; A P Wilson; D J Betteridge
Journal:  Clin Auton Res       Date:  1993-02       Impact factor: 4.435

9.  Possible platelet thrombi formation in dog and human femoral arteries.

Authors:  J D Folts; D E Detmer; R Nadler
Journal:  Tex Heart Inst J       Date:  1982-03

10.  Aspirin resistance: A fact or a myth?

Authors:  Gundu Hr Rao
Journal:  Exp Clin Cardiol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.